The Underestimated Burden of Monogenic Diseases in Adult-Onset ESRD
Author(s) -
Émilie Cornec-Le Gall,
Peter C. Harris
Publication year - 2018
Publication title -
journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.451
H-Index - 279
eISSN - 1533-3450
pISSN - 1046-6673
DOI - 10.1681/asn.2018040441
Subject(s) - nephronophthisis , medicine , nephrology , pediatrics , polyuria , disease , kidney disease , newborn screening , endocrinology , genetics , diabetes mellitus , biology , gene , phenotype
The primary cause of ESRD remains unresolved in 15%–20% of adult patients, a percentage probably underestimated considering that the nonspecific diagnoses of hypertension- and renal vascular–related CKD represent 20%–25% of patients with ESRD.[1][1],[2][2] As genomic testing is more commonly
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom